Your Health and Fitness Partner: Androxal & FitHub

We are also excited to expand our scope by including valuable information on Androxal, a potent medication beneficial in various medical conditions. This remarkable drug, derived from the testosterone molecule, has made its mark significantly in the field of endocrinology. Patients and medical professionals can rely on our comprehensive, unbiased, and scientifically grounded content on Androxal for gaining a robust understanding of its uses, side effects, and the latest studies related to it. We understand the necessity of accurate information when it comes to medication. Our newly launched section dedicated to Androxal aims at not only educating the readers about its nuances but also at contributing beneficially to their wellbeing. Stay tuned for insightful articles unraveling the potential of Androxal in medical science.

Sitemap | Policies | Feedback    
 About the Journal
Editorial Board
Journal Subscription
Instructions for Authors
E-mail Alerts
Forthcoming Events
Advertise with Us
Contact Us
 
Article Options
FULL TEXT
ABSTRACT
PDF
Printer Friendly Version
Search Pubmed for
Search Google Scholar for
Article Statistics
Bookmark and Share
 
Biliary Cystadenoma: A Rare Entity of Common Misdiagnosis - An Institutional Experience
 
Nagari Bheerappa1, Digvijoy Sharma1, Gangadhar Rao Gondu1, Venu Madhav Thamma1, Surya Ramachandra Varma Gunturi1, Shantveer G Uppin2, Kunduru Nava Kishore1, Jagan Mohan Reddy1
1Department of Surgical Gastroenterology, 2Department of Pathology, Nizams Institute of Medical Sciences, Hyderabad, Telangana, India.


Corresponding Author
:
Dr Nagari Bheerappa
Email: nbheerappa62@gmail.com


Abstract

Background: Biliary cystadenomas are rare  benign neoplasm of the liver with a few hundred cases being reported all over the world. We herein report a series of 12 cases stressing on the importance of imaging and surgery in the management of this rare entity which is often misdiagnosed .
Materials and Methods: Records of 12 patients who underwent surgery for biliary cystadenomas between January 2010 to October 2017, were reviewed retrospectively.
Results: All the 12 patients in the were females with a median age of presentation of 36 (20-55) years. The most frequent symptom was abdominal pain (100%). 4 patients were misdiagnosed as hydatid cyst and one as simple cyst of liver. These were operated elsewhere and presented with recurrence after a median period of 6 months. Liver resection was performed in 8 patients and enucleation in other 4. No recurrence was reported during the follow-up period ranging from 3 months to 7 years. 
Conclusion: Biliary cystadenoma closely mimics other cystic space occupying lesions (SOL) of liver and needs to be differentiated from the same, as the treatment varies. Hepatic resection or enucleation of the cyst is the recommended treatment .